Regenerative Medicine Is Growing, and Clients Want More Transparency
Interest in regenerative medicine continues to grow as Americans look for new approaches to health, recovery, and longevity.
Grand View Research estimates the U.S. regenerative medicine market generated about $19.5 billion in 2024 and projects it will reach $49.3 billion by 2030. As the field grows, so do the questions clients ask about what is actually being provided and whether it may be right for them.
TreVita is seeing these shifts firsthand. The company is expanding its regenerative medicine program in Zona Río, Baja California, Mexico, broadening its stem cell services into areas like healthy aging and rejuvenation and sports and orthopedic injuries. That growth points to a bigger change in how clients approach regenerative care, with more focus on:
TreVita’s press release on its regenerative medicine expansion is featured on AP News. Here’s a closer look at what’s behind it.
A Broader Regenerative Medicine Program
TreVita is broadening its existing stem cell services across additional areas of regenerative medicine, including:
Rather than offering predetermined treatment packages, TreVita’s regenerative medicine program starts with individualized physician evaluation.
Physicians evaluate a client’s medical history, current condition, diagnostic information, and treatment goals before determining whether the client may be an appropriate candidate and what approach, if any, should be considered.
The expansion reflects TreVita’s growing focus on regenerative medicine as a core part of its medical travel platform.
A More Individualized Experience
Regenerative medicine is highly individualized, and it should not be approached as a one-size-fits-all experience.
TreVita’s program centers on individualized physician evaluation and treatment planning, with the goal of helping clients understand their options and set realistic expectations before moving forward.
The program also puts a strong emphasis on transparency around the cellular products clients receive. This includes information such as the cell type and source, cell count, viability, delivery method, testing, and documentation, along with the physician’s rationale for the treatment plan.
For clients considering regenerative medicine, knowing that a treatment involves stem cells is only part of the picture.
Stem cell therapy is not a cure, and outcomes are not guaranteed. Results vary from person to person, and a physician’s evaluation is the best way to understand whether it may be appropriate for you. If you’re new to the topic, these 10 things to know about stem cell therapy are a helpful place to start.
Where TreVita Is Going Next
TreVita is developing additional clinical and laboratory capabilities in Zona Río that will give it greater involvement across the client journey, from medical evaluation and treatment coordination to cellular quality oversight and follow-up care.
Rather than focusing only on getting clients from one location to another, TreVita is building a model that connects physicians, science, cellular products, and the client experience.
Throughout, TreVita’s role is to coordinate care and connect clients with experienced physicians, who make treatment recommendations based on each person’s medical circumstances.
Read the Full Press Release
Want to know what’s behind the expansion?
TreVita’s press release is featured on the AP News platform.
Read the Full Press Release on AP News